Home2LB • FRA
add
Iovance Biotherapeutics Inc
Nakaraang pagsara
€1.58
Sakop ng araw
€1.50 - €1.50
Sakop ng taon
€1.50 - €11.60
Market cap
586.01M USD
Average na Volume
1.43K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Sa balita
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Mar 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 49.32M | 6,798.46% |
Gastos sa pagpapatakbo | 120.80M | 8.66% |
Net na kita | -116.16M | -2.82% |
Net profit margin | -235.51 | 98.51% |
Kita sa bawat share | -0.36 | 14.29% |
EBITDA | -113.03M | -2.65% |
Aktuwal na % ng binabayarang buwis | 1.56% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Mar 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 359.71M | 0.99% |
Kabuuang asset | 966.74M | 11.14% |
Kabuuang sagutin | 198.88M | 4.78% |
Kabuuang equity | 767.86M | — |
Natitirang share | 333.93M | — |
Presyo para makapag-book | 0.69 | — |
Return on assets | -32.29% | — |
Return on capital | -38.11% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -116.16M | -2.82% |
Cash mula sa mga operasyon | -103.69M | 15.20% |
Cash mula sa pag-invest | 15.87M | 114.23% |
Cash mula sa financing | 143.32M | -25.96% |
Net change in cash | 56.00M | 237.58% |
Malayang cash flow | -63.94M | 22.41% |
Tungkol
Iovance Biotherapeutics, Inc. is a biopharmaceutical startup based in San Carlos, California. The company works to develop tumor-infiltrating lymphocyte therapies against cancer. Wikipedia
Itinatag
2007
Headquarters
Website
Mga Empleyado
838
